XML 34 R24.htm IDEA: XBRL DOCUMENT v3.25.3
Product Acquisitions and Return of Product Rights (Tables)
9 Months Ended
Sep. 30, 2025
Business Combination [Abstract]  
Business combination, contingent consideration
The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis. The contingent consideration earned and accrued in operating expenses is paid to Theravance quarterly.
Balance at December 31, 2024
$3,242,999 
Cash payment of royalty during the period(503,512)
Change in fair value of contingent consideration included in operating expenses71,715 
Contingent consideration earned and accrued in operating expenses751,465 
Balance at September 30, 2025
$3,562,667 
The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis.
Balance at December 31, 2024
$1,516,000 
Cash payment of milestones and royalty during the period(527,685)
Change in fair value of contingent consideration included in operating expenses(164,944)
Contingent consideration earned and accrued in operating expenses451,629 
Balance at September 30, 2025
$1,275,000